QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NYSE:CPHI

China Pharma (CPHI) Stock Forecast, Price & News

$0.14
-0.01 (-6.87%)
(As of 09/21/2023 ET)
Compare
Today's Range
$0.13
▼
$0.15
50-Day Range
$0.14
▼
$0.36
52-Week Range
$0.11
▼
$2.46
Volume
642,705 shs
Average Volume
555,663 shs
Market Capitalization
$1.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media

CPHI stock logo

About China Pharma (NYSE:CPHI) Stock

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. The company also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. The company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

CPHI Price History

CPHI Stock News Headlines

September 17, 2023 | americanbankingnews.com
China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com
September 16, 2023 | investing.com
China NT Pharma Group Co Ltd (1011)
September 21, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
August 27, 2023 | msn.com
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
August 24, 2023 | finance.yahoo.com
Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?
August 23, 2023 | msn.com
Signal: Chinese economic slump hurts pharma firms invested in the region
August 9, 2023 | msn.com
Gov’t scientists got $325M in royalties from China, Russia, pharma firms
August 9, 2023 | markets.businessinsider.com
China Pharma: Candesartan Tablets Passes Generic-drug-consistency-evaluation
September 21, 2023 | Behind the Markets (Ad)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
August 9, 2023 | finance.yahoo.com
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs
July 27, 2023 | msn.com
Pharmaniaga teams up with China's CSPC to boost biopharmaceutical development
July 5, 2023 | reuters.com
China's commerce minister met with foreign pharmaceuticals firms on Wednesday - Commerce Ministry
June 3, 2023 | msn.com
FDA to allow imports of cancer drug from China amid ongoing shortage
May 28, 2023 | reuters.com
China regulator fines two pharma firms for monopoly behaviour
May 5, 2023 | finance.yahoo.com
Viva Biotech's Recent Conferences & Events Review
April 28, 2023 | marketwatch.com
Ox Bezoars (Cow Bezoars) Market Research Analysis 2023-2031
April 20, 2023 | markets.businessinsider.com
Aurisco Expands Oligonucleotide Capacity and Launches New Website
February 27, 2023 | finanznachrichten.de
China Pharma Holdings, Inc.: China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
February 25, 2023 | marketwatch.com
Ox Bezoars (Cow Bezoars) Market Intelligence Report [2023-2028] | Get Ahead of Your Competitors with Our New Report
February 24, 2023 | msn.com
China Pharma launches 1-for-10 reverse stock split
February 24, 2023 | finance.yahoo.com
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
January 25, 2023 | dailymail.co.uk
Antifa terror suspect daughter of Pharma China giant and British Foreign Office consultant
December 28, 2022 | markets.businessinsider.com
China Pharma Launches N95 Mask - Quick Facts
December 28, 2022 | finance.yahoo.com
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask
December 15, 2022 | finance.yahoo.com
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19
December 5, 2022 | marketwatch.com
China Pharma Shares More Than Double After Acquisition of Dry Eye Disease Device Project
December 5, 2022 | finance.yahoo.com
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project
See More Headlines
Receive CPHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPHI Company Calendar

Last Earnings
8/14/2023
Today
9/21/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:CPHI
CUSIP
N/A
CIK
1106644
Web
www.chinapharmaholdings.com
Phone
8689866811730
Fax
86-898-6681-9024
Employees
234
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,970,000.00
Net Margins
-39.33%
Pretax Margin
-39.33%
Return on Equity
-77.41%
Return on Assets
-18.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.52
Quick Ratio
0.15

Sales & Book Value

Annual Sales
$8.10 million
Price / Sales
0.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
0.24

Miscellaneous

Outstanding Shares
11,430,000
Free Float
5,854,000
Market Cap
$1.55 million
Optionable
Not Optionable
Beta
0.53
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Ms. Zhilin Li (Age 70)
    Pres, CEO, Chairman & Interim CFO
  • Ms. Huang Na C.F.A.
    BOD Sec. & IR Mang.

Key Competitors

View All Competitors













CPHI Stock - Frequently Asked Questions

How have CPHI shares performed in 2023?

China Pharma's stock was trading at $0.63 at the start of the year. Since then, CPHI stock has decreased by 78.5% and is now trading at $0.1355.
View the best growth stocks for 2023 here.

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSE:CPHI) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.06) EPS for the quarter. The business had revenue of $1.10 million for the quarter. China Pharma had a negative trailing twelve-month return on equity of 77.41% and a negative net margin of 39.33%.

When did China Pharma's stock split?

Shares of China Pharma reverse split on Monday, March 6th 2023. The 1-10 reverse split was announced on Monday, March 6th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), Bionano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), AMC Entertainment (AMC).

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "CPHI."

How do I buy shares of China Pharma?

Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.14.

How much money does China Pharma make?

China Pharma (NYSE:CPHI) has a market capitalization of $1.55 million and generates $8.10 million in revenue each year.

How many employees does China Pharma have?

The company employs 234 workers across the globe.

How can I contact China Pharma?

China Pharma's mailing address is Second Floor No. 17 Jinpan Road, Haikou F4, 570216. The official website for the company is www.chinapharmaholdings.com. The company can be reached via phone at 8689866811730, via email at hps@chinapharmaholdings.com, or via fax at 86-898-6681-9024.

This page (NYSE:CPHI) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -